Vong John
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
1,813 |
10,340
(0%)
|
0%
|
|
0
|
Common Stock |
Schmidt David G.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
5,750 |
5,750
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
30,000 |
351,859
(0%)
|
0%
|
|
0
|
Common Stock |
Vong John
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
7,100 |
19,253
(0%)
|
0%
|
|
0
|
Common Stock |
Vong John
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
1,813 |
8,527
(0%)
|
0%
|
|
0
|
Common Stock |
Lam S. Thomas
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
30,000 |
321,855
(0%)
|
0%
|
|
0
|
Common Stock |
Mitchell Kitayama W.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
6,750 |
6,750
(0%)
|
0%
|
|
0
|
Common Stock |
S. Lam Thomas
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
30,000 |
381,855
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
30,000 |
381,859
(0%)
|
0%
|
|
0
|
Common Stock |
Matthew Mazdyasni
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
4,750 |
4,750
(0%)
|
0%
|
|
0
|
Common Stock |
Vong John
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
1,813 |
6,714
(0%)
|
0%
|
|
0
|
Common Stock |
John Vong
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
1,813 |
12,153
(0%)
|
0%
|
|
0
|
Common Stock |
Chiang John
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
4,750 |
4,850
(0%)
|
0%
|
|
0
|
Common Stock |
Sim Kenneth
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
30,000 |
321,859
(0%)
|
0%
|
|
0
|
Common Stock |
Weili Dai
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
3,650 |
3,650
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas Lam S.
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
30,000 |
351,855
(0%)
|
0%
|
|
0
|
Common Stock |
Linda Marsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Dec 2023 |
3,650 |
66,150
(0%)
|
0%
|
|
0
|
Common Stock |
David Schmidt G.
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.11 per share. |
06 Dec 2023 |
7,500 |
7,500
(0%)
|
0%
|
18.1 |
135,825
|
Common Stock |
David G. Schmidt
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Dec 2023 |
7,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Schmidt David G.
|
Director |
Sale or transfer of securities back to the company at price $ 33.49 per share. |
06 Dec 2023 |
7,500 |
0
(0%)
|
0%
|
33.5 |
251,175
|
Common Stock |
W. Kitayama Mitchell
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.11 per share. |
06 Dec 2023 |
7,500 |
7,500
(0%)
|
0%
|
18.1 |
135,825
|
Common Stock |
Kitayama Mitchell W.
|
Director |
Sale or transfer of securities back to the company at price $ 33.49 per share. |
06 Dec 2023 |
7,500 |
0
(0%)
|
0%
|
33.5 |
251,175
|
Common Stock |
Kitayama W. Mitchell
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Dec 2023 |
7,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
John Vong
|
Chief Accounting Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.23 per share. |
30 Nov 2023 |
65 |
4,901
(0%)
|
0%
|
33.2 |
2,160
|
Common Stock |
Brandon Sim
|
Co-Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 May 2023 |
380,053 |
902,620
(1%)
|
0%
|
|
0
|
Common Stock |
Chandan Basho
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 May 2023 |
130,732 |
207,671
(0%)
|
0%
|
|
0
|
Common Stock |
Linda Marsh
|
Director |
Sale or transfer of securities back to the company at price $ 35.32 per share. |
14 Mar 2023 |
270,081 |
0
(0%)
|
0%
|
35.3 |
9,539,261
|
Common Stock |
John Vong
|
SVP-Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2022 |
1,388 |
5,159
(0%)
|
0%
|
|
0
|
Common Stock |
John Vong
|
SVP-Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2022 |
694 |
7,935
(0%)
|
0%
|
|
0
|
Common Stock |
John Vong
|
SVP-Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2022 |
694 |
7,241
(0%)
|
0%
|
|
0
|
Common Stock |
John Vong
|
SVP-Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2022 |
1,388 |
6,547
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. |
08 Dec 2022 |
48,587 |
291,859
(0%)
|
0%
|
11 |
534,457
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
08 Dec 2022 |
51,445 |
243,272
(0%)
|
0%
|
10 |
514,450
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Dec 2022 |
48,587 |
0
|
-
|
|
-
|
Warrants to purchase Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Dec 2022 |
51,445 |
0
|
-
|
|
-
|
Warrants to purchase Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Dec 2022 |
51,442 |
0
|
-
|
|
-
|
Warrants to purchase Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
05 Dec 2022 |
51,443 |
243,270
(0%)
|
0%
|
10 |
514,430
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. |
05 Dec 2022 |
48,585 |
291,855
(0%)
|
0%
|
11 |
534,435
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Dec 2022 |
48,585 |
0
|
-
|
|
-
|
Warrants to purchase Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
02 Dec 2022 |
984,042 |
10,191,660
(19%)
|
1%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
02 Dec 2022 |
37,439 |
1,107,474
(2%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Other type of transaction at price $ 0.00 per share. |
02 Dec 2022 |
984,042 |
10,191,660
(19%)
|
1%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Other type of transaction at price $ 0.00 per share. |
02 Dec 2022 |
37,439 |
520,117
(0%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Other type of transaction at price $ 0.00 per share. |
02 Dec 2022 |
984,042 |
10,191,660
(19%)
|
1%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Other type of transaction at price $ 0.00 per share. |
02 Dec 2022 |
19,506 |
1,184,749
(2%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. |
29 Nov 2022 |
26,828 |
1,165,243
(2%)
|
0%
|
11 |
295,108
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Nov 2022 |
28,406 |
0
|
-
|
|
-
|
Warrants to purchase Common Stock |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Nov 2022 |
26,828 |
0
|
-
|
|
-
|
Warrants to purchase Common Stock |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
29 Nov 2022 |
28,406 |
1,138,415
(2%)
|
0%
|
10 |
284,060
|
Common Stock |
Brandon Sim
|
Co- Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jun 2022 |
198,511 |
491,134
(0%)
|
0%
|
|
0
|
Common Stock |
Brandon Sim
|
Co- Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jun 2022 |
108,560 |
292,623
(0%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.47 per share. |
31 Mar 2022 |
256 |
1,110,009
(2%)
|
0%
|
48.5 |
12,408
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.47 per share. |
31 Mar 2022 |
469 |
20,844
(0%)
|
0%
|
48.5 |
22,732
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
03 Mar 2022 |
200,000 |
799,855
(1%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
03 Mar 2022 |
383,764 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
03 Mar 2022 |
383,764 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Gift of securities by or to the insider at price $ 0.00 per share. |
25 Feb 2022 |
392,816 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Gift of securities by or to the insider at price $ 0.00 per share. |
25 Feb 2022 |
258,824 |
230,576
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Gift of securities by or to the insider at price $ 0.00 per share. |
25 Feb 2022 |
392,816 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Brandon Sim
|
Co-CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
25 Feb 2022 |
392,816 |
392,816
(0%)
|
0%
|
|
0
|
Common Stock |
Brandon Sim
|
Co-CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
25 Feb 2022 |
258,824 |
258,824
(0%)
|
0%
|
|
0
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. |
03 Feb 2022 |
2,802 |
21,313
(0%)
|
0%
|
50.7 |
142,089
|
Common Stock |
Mitchell W. Kitayama
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
Ernest A. Bates
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
David G. Schmidt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Fawcett
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
Michael F. Eng
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
Linda Marsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
John Chiang
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
Matthew Mazdyasni
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jan 2022 |
8,500 |
8,500
|
-
|
|
-
|
Stock Option (right to buy) |
Kenneth Sim
|
Director, Executive Chairman |
Gift of securities by or to the insider at price $ 0.00 per share. |
04 Nov 2021 |
230,688 |
397,724
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Nov 2021 |
29,502 |
29,502
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas S. Lam
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Nov 2021 |
65,242 |
191,827
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Nov 2021 |
65,242 |
191,827
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Nov 2021 |
29,502 |
29,502
|
-
|
|
-
|
Stock Option (right to buy) |
Brandon Sim
|
Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Nov 2021 |
54,486 |
54,486
|
-
|
|
-
|
Stock Option (right to buy) |
Brandon Sim
|
Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Nov 2021 |
42,451 |
184,063
(0%)
|
0%
|
|
0
|
Common Stock |
David G. Schmidt
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.20 per share. |
17 Aug 2021 |
40,000 |
40,000
(0%)
|
0%
|
5.2 |
208,000
|
Common Stock |
David G. Schmidt
|
Director |
Sale of securities on an exchange or to another person at price $ 73.67 per share. |
17 Aug 2021 |
40,000 |
0
(0%)
|
0%
|
73.7 |
2,946,800
|
Common Stock |
David G. Schmidt
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
17 Aug 2021 |
40,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Albert Young
|
Chief Administrative Officer |
Sale of securities on an exchange or to another person at price $ 48.58 per share. |
15 Jun 2021 |
5,000 |
1,110,265
(2%)
|
0%
|
48.6 |
242,900
|
Common Stock |
Brandon Sim
|
See Remarks |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.88 per share. |
31 May 2021 |
5,426 |
141,612
(0%)
|
0%
|
34.9 |
189,259
|
Common Stock |
Brandon Sim
|
See Remarks |
Purchase of securities on an exchange or from another person at price $ 31.40 per share. |
13 May 2021 |
1,000 |
147,038
(0%)
|
0%
|
31.4 |
31,400
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 24.50 per share. |
28 Apr 2021 |
100,000 |
371,004
(0%)
|
0%
|
24.5 |
2,450,000
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
30 Mar 2021 |
31,755 |
908,183
(1%)
|
0%
|
10 |
317,550
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Mar 2021 |
31,755 |
0
|
-
|
|
-
|
Warrant to Purchase Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
30 Mar 2021 |
31,756 |
859,101
(1%)
|
0%
|
10 |
317,560
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Mar 2021 |
31,756 |
0
|
-
|
|
-
|
Warrant to Purchase Common Stock |
Eric Chin
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Mar 2021 |
8,606 |
24,670
(0%)
|
0%
|
|
0
|
Common Stock |
Brandon Sim
|
COO, CTO and VP of Engineering |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Mar 2021 |
59,165 |
146,038
(0%)
|
0%
|
|
0
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Feb 2021 |
6,867 |
16,064
(0%)
|
0%
|
|
0
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Feb 2021 |
3,103 |
3,103
|
-
|
|
-
|
Stock Option (right to buy) |
Brandon Sim
|
COO, CTO and VP of Engineering |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Feb 2021 |
21,334 |
21,334
|
-
|
|
-
|
Stock Option (right to buy) |
Brandon Sim
|
COO, CTO and VP of Engineering |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Feb 2021 |
47,210 |
86,873
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
22 Dec 2020 |
185,938 |
876,428
(1%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
22 Dec 2020 |
31,755 |
908,183
(1%)
|
0%
|
10 |
317,550
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
22 Dec 2020 |
31,756 |
859,100
(1%)
|
0%
|
10 |
317,560
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
22 Dec 2020 |
185,938 |
827,344
(1%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Other type of transaction at price $ 0.00 per share. |
22 Dec 2020 |
96,877 |
1,115,265
(2%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Dec 2020 |
29,502 |
29,502
|
-
|
|
-
|
Stock Option (right to buy) |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Dec 2020 |
65,242 |
126,585
(0%)
|
0%
|
|
0
|
Common Stock |
Mitchell W. Kitayama
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Ernest A. Bates
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Li Yu
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
David G. Schmidt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Fawcett
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Michael F. Eng
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Linda Marsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
John Chiang
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Matthew Mazdyasni
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Nov 2020 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas S. Lam
|
Director, President and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 17.28 per share. |
14 Sep 2020 |
5,000 |
690,490
(1%)
|
0%
|
17.3 |
86,381
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 17.23 per share. |
14 Sep 2020 |
5,000 |
42,996
(0%)
|
0%
|
17.2 |
86,168
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 17.20 per share. |
14 Sep 2020 |
1,000 |
17,379
(0%)
|
0%
|
17.2 |
17,204
|
Common Stock |
Brandon Sim
|
See Remarks |
Purchase of securities on an exchange or from another person at price $ 17.20 per share. |
14 Sep 2020 |
1,000 |
17,379
(0%)
|
0%
|
17.2 |
17,204
|
Common Stock |
Brandon Sim
|
See Remarks |
Purchase of securities on an exchange or from another person at price $ 17.23 per share. |
14 Sep 2020 |
5,000 |
42,996
(0%)
|
0%
|
17.2 |
86,168
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.00 per share. |
11 Sep 2020 |
602 |
471,004
(0%)
|
0%
|
18 |
10,836
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
10 Sep 2020 |
564,691 |
685,490
(1%)
|
1%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
10 Sep 2020 |
564,691 |
564,691
(1%)
|
1%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 17.60 per share. |
10 Sep 2020 |
5,000 |
37,996
(0%)
|
0%
|
17.6 |
88,000
|
Common Stock |
Brandon Sim
|
See Remarks |
Purchase of securities on an exchange or from another person at price $ 17.60 per share. |
10 Sep 2020 |
5,000 |
37,996
(0%)
|
0%
|
17.6 |
88,000
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
09 Sep 2020 |
564,706 |
641,407
(1%)
|
1%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
09 Sep 2020 |
564,706 |
564,706
(1%)
|
1%
|
|
0
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.00 per share. |
08 Sep 2020 |
7,484 |
471,606
(0%)
|
0%
|
18 |
134,712
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.15 per share. |
08 Sep 2020 |
5,783 |
479,090
(0%)
|
0%
|
18.1 |
104,949
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 17.85 per share. |
08 Sep 2020 |
5,000 |
1,814,872
(3%)
|
0%
|
17.9 |
89,250
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.89 per share. |
08 Sep 2020 |
30,252 |
1,809,872
(3%)
|
0%
|
18.9 |
571,460
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. |
08 Sep 2020 |
63,510 |
1,840,124
(3%)
|
0%
|
9 |
571,590
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Sep 2020 |
63,510 |
0
|
-
|
|
-
|
Warrants to Purchase Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 18.23 per share. |
27 Aug 2020 |
5,000 |
1,776,614
(3%)
|
0%
|
18.2 |
91,150
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 18.34 per share. |
27 Aug 2020 |
5,000 |
1,770,556
(3%)
|
0%
|
18.3 |
91,700
|
Common Stock |
Brandon Sim
|
See Remarks, Item 2 |
Purchase of securities on an exchange or from another person at price $ 18.34 per share. |
27 Aug 2020 |
5,000 |
1,770,556
(3%)
|
0%
|
18.3 |
91,700
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 17.23 per share. |
05 Jun 2020 |
29,185 |
489,073
(0%)
|
0%
|
17.2 |
502,858
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 17.09 per share. |
05 Jun 2020 |
4,200 |
484,873
(0%)
|
0%
|
17.1 |
71,778
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.00 per share. |
03 Jun 2020 |
2,683 |
518,258
(0%)
|
0%
|
18 |
48,294
|
Common Stock |
Hing Ang
|
Chief Operating Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
26 May 2020 |
2,444 |
38,316
(0%)
|
0%
|
|
0
|
Common Stock |
Mark Fawcett
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. |
06 May 2020 |
20,000 |
30,000
(0%)
|
0%
|
5 |
100,000
|
Common Stock |
Mark Fawcett
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
06 May 2020 |
20,000 |
36,909
|
-
|
|
-
|
Stock Option (right to buy) |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. |
31 Mar 2020 |
35,069 |
1,001,109
(1%)
|
0%
|
9 |
315,621
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
31 Mar 2020 |
17,534 |
1,018,643
(1%)
|
0%
|
10 |
175,340
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2020 |
35,069 |
0
|
-
|
|
-
|
Warrants to Purchase Common Stock |
Albert Young
|
Chief Administrative Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Mar 2020 |
17,534 |
0
|
-
|
|
-
|
Warrants to Purchase Common Stock |
Albert Young
|
Chief Administrative Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.92 per share. |
31 Mar 2020 |
256 |
966,040
(1%)
|
0%
|
12.9 |
3,308
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 14.90 per share. |
31 Mar 2020 |
2,040 |
9,197
(0%)
|
0%
|
14.9 |
30,396
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.92 per share. |
31 Mar 2020 |
555 |
7,157
(0%)
|
0%
|
12.9 |
7,171
|
Common Stock |
Linda Marsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Mar 2020 |
62,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Linda Marsh
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
04 Mar 2020 |
62,500 |
62,500
(0%)
|
0%
|
10 |
625,000
|
Common Stock |
Linda Marsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Mar 2020 |
62,500 |
62,500
|
-
|
|
-
|
Stock Option (right to buy) |
Linda Marsh
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
04 Mar 2020 |
62,500 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Mitchell W. Kitayama
|
Director |
Other type of transaction at price $ 0.00 per share. |
05 Feb 2020 |
2,048 |
18,500
|
-
|
|
-
|
Stock Option (right to buy) |
Mitchell W. Kitayama
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2020 |
3,409 |
21,909
|
-
|
|
-
|
Stock Option (right to buy) |
David G. Schmidt
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2020 |
3,409 |
101,909
|
-
|
|
-
|
Stock Option (right to buy) |
David G. Schmidt
|
Director |
Other type of transaction at price $ 0.00 per share. |
05 Feb 2020 |
2,048 |
98,500
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Fawcett
|
Director |
Other type of transaction at price $ 0.00 per share. |
05 Feb 2020 |
2,048 |
53,500
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Fawcett
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2020 |
3,409 |
56,909
|
-
|
|
-
|
Stock Option (right to buy) |
Hing Ang
|
Chief Operating Officer |
Other type of transaction at price $ 0.00 per share. |
05 Feb 2020 |
3,674 |
37,593
(0%)
|
0%
|
|
0
|
Common Stock |
Hing Ang
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2020 |
3,666 |
41,259
(0%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2020 |
1,880 |
966,296
(1%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Other type of transaction at price $ 0.00 per share. |
05 Feb 2020 |
1,885 |
916,446
(1%)
|
0%
|
|
0
|
Common Stock |
Eric Chin
|
CFO & Corporate Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2020 |
4,073 |
7,712
(0%)
|
0%
|
|
0
|
Common Stock |
Eric Chin
|
CFO & Corporate Secretary |
Other type of transaction at price $ 0.00 per share. |
05 Feb 2020 |
4,083 |
3,639
(0%)
|
0%
|
|
0
|
Common Stock |
John Chiang
|
Director |
Other type of transaction at price $ 0.00 per share. |
05 Feb 2020 |
900 |
11,000
|
-
|
|
-
|
Stock Option (right to buy) |
John Chiang
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2020 |
1,515 |
12,515
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas S. Lam
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2019 |
28,046 |
28,046
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas S. Lam
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2019 |
61,343 |
61,343
(0%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2019 |
28,046 |
28,046
|
-
|
|
-
|
Stock Option (right to buy) |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2019 |
61,343 |
61,343
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
27 Dec 2019 |
58,883 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
27 Dec 2019 |
39,189 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
27 Dec 2019 |
39,189 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Other type of transaction at price $ 0.00 per share. |
27 Dec 2019 |
58,883 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2019 |
93,450 |
17,158,389
(32%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, President and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2019 |
86,874 |
1,830,497
(3%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2019 |
93,450 |
17,158,389
(32%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2019 |
86,878 |
1,824,439
(3%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2019 |
47,970 |
966,301
(1%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2019 |
93,450 |
17,158,389
(32%)
|
0%
|
|
0
|
Common Stock |
Michael F. Eng
|
None |
Purchase of securities on an exchange or from another person at price $ 18.48 per share. |
04 Dec 2019 |
1,890 |
4,890
(0%)
|
0%
|
18.5 |
34,927
|
Common Stock |
Hing Ang
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Nov 2019 |
3,674 |
41,267
(0%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Chief Administrative Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Nov 2019 |
1,885 |
918,331
(1%)
|
0%
|
|
0
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Nov 2019 |
4,083 |
7,722
(0%)
|
0%
|
|
0
|
Common Stock |
Mitchell W. Kitayama
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
2,048 |
20,548
|
-
|
|
-
|
Stock Options |
David G. Schmidt
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
2,048 |
100,548
|
-
|
|
-
|
Stock Options |
Mark Fawcett
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
2,048 |
55,548
|
-
|
|
-
|
Stock Options |
John Chiang
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
900 |
11,900
|
-
|
|
-
|
Stock Options |
Thomas S. Lam
|
Director, President and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 14.84 per share. |
14 Nov 2019 |
10,000 |
1,743,623
(3%)
|
0%
|
14.8 |
148,400
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 14.67 per share. |
14 Nov 2019 |
10,000 |
1,737,561
(3%)
|
0%
|
14.7 |
146,700
|
Common Stock |
Mitchell W. Kitayama
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
18,500
|
-
|
|
-
|
Stock Options |
Ernest A. Bates
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
18,500
|
-
|
|
-
|
Stock Options |
Li Yu
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
18,500
|
-
|
|
-
|
Stock Options |
David G. Schmidt
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
98,500
|
-
|
|
-
|
Stock Options |
Mark Fawcett
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
53,500
|
-
|
|
-
|
Stock Options |
Michael F. Eng
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
18,500
|
-
|
|
-
|
Stock Options |
Linda Marsh
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
73,500
|
-
|
|
-
|
Stock Options |
John Chiang
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Oct 2019 |
11,000 |
11,000
|
-
|
|
-
|
Stock Options |
Kenneth Sim
|
Director, Executive Chairman and Co-CEO |
Purchase of securities on an exchange or from another person at price $ 15.55 per share. |
08 Oct 2019 |
5,000 |
1,727,561
(3%)
|
0%
|
15.6 |
77,750
|
Common Stock |
Michael F. Eng
|
None |
Purchase of securities on an exchange or from another person at price $ 20.28 per share. |
12 Sep 2019 |
2,000 |
3,000
(0%)
|
0%
|
20.3 |
40,560
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 19.77 per share. |
11 Sep 2019 |
27,350 |
520,941
(0%)
|
0%
|
19.8 |
540,710
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 20.14 per share. |
11 Sep 2019 |
13,746 |
548,291
(1%)
|
0%
|
20.1 |
276,844
|
Common Stock |
Adrian Vazquez
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 20.14 per share. |
11 Sep 2019 |
43,704 |
562,037
(1%)
|
0%
|
20.1 |
880,199
|
Common Stock |
Thomas S. Lam
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2019 |
15,015,015 |
16,790,575
(31%)
|
41%
|
|
-
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2019 |
15,015,015 |
16,790,575
(31%)
|
41%
|
|
-
|
Common Stock |
Albert Young
|
Co-Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2019 |
15,015,015 |
16,750,575
(31%)
|
41%
|
|
-
|
Common Stock |
Michael F. Eng
|
None |
Purchase of securities on an exchange or from another person at price $ 15.97 per share. |
19 Aug 2019 |
1,000 |
1,000
(0%)
|
0%
|
16.0 |
15,970
|
Common Stock |
Thomas S. Lam
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 15.57 per share. |
14 Aug 2019 |
4,000 |
1,668,740
(3%)
|
0%
|
15.6 |
62,280
|
Common Stock |
Thomas S. Lam
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 16.19 per share. |
14 Aug 2019 |
6,000 |
1,674,740
(3%)
|
0%
|
16.2 |
97,140
|
Common Stock |
Thomas S. Lam
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 16.85 per share. |
14 Aug 2019 |
7,200 |
1,664,740
(3%)
|
0%
|
16.9 |
121,320
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 16.23 per share. |
14 Aug 2019 |
2,000 |
1,659,678
(3%)
|
0%
|
16.2 |
32,460
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 15.25 per share. |
14 Aug 2019 |
1,500 |
1,661,178
(3%)
|
0%
|
15.3 |
22,875
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 16.35 per share. |
14 Aug 2019 |
563 |
1,663,678
(3%)
|
0%
|
16.3 |
9,205
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 16.35 per share. |
14 Aug 2019 |
437 |
1,663,115
(3%)
|
0%
|
16.4 |
7,145
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 16.25 per share. |
14 Aug 2019 |
1,500 |
1,662,678
(3%)
|
0%
|
16.3 |
24,375
|
Common Stock |
Albert Young
|
Co-Chief Medical Officer |
Purchase of securities on an exchange or from another person at price $ 15.01 per share. |
14 Aug 2019 |
5,000 |
916,446
(1%)
|
0%
|
15.0 |
75,050
|
Common Stock |
John Chiang
|
None |
Purchase of securities on an exchange or from another person at price $ 16.31 per share. |
14 Jun 2019 |
100 |
100
(0%)
|
0%
|
16.3 |
1,631
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 14.72 per share. |
12 Jun 2019 |
2,040 |
3,639
(0%)
|
0%
|
14.7 |
30,029
|
Common Stock |
Mark Fawcett
|
None |
Purchase of securities on an exchange or from another person at price $ 14.13 per share. |
11 Jun 2019 |
10,000 |
10,000
(0%)
|
0%
|
14.1 |
141,300
|
Common Stock |
Thomas S. Lam
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 14.64 per share. |
11 Jun 2019 |
6,900 |
1,657,540
(3%)
|
0%
|
14.6 |
101,016
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 14.45 per share. |
11 Jun 2019 |
1,300 |
1,657,678
(3%)
|
0%
|
14.5 |
18,785
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Purchase of securities on an exchange or from another person at price $ 14.51 per share. |
11 Jun 2019 |
5,696 |
1,656,378
(3%)
|
0%
|
14.5 |
82,649
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 16.01 per share. |
03 Jun 2019 |
38,051 |
605,741
(1%)
|
0%
|
16.0 |
609,056
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 16.64 per share. |
03 Jun 2019 |
46,949 |
643,792
(1%)
|
0%
|
16.6 |
781,114
|
Common Stock |
Eric Chin
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jan 2019 |
1,599 |
1,599
(0%)
|
0%
|
|
0
|
Common Stock |
Mitchell W. Kitayama
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2019 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options |
Ernest A. Bates
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2019 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options |
Li Yu
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2019 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options |
David G. Schmidt
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2019 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options |
Mark Fawcett
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2019 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options |
Michael F. Eng
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2019 |
7,500 |
7,500
|
-
|
|
-
|
Stock Options |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2018 |
86,876 |
1,650,640
(4%)
|
0%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2018 |
93,451 |
1,775,560
(5%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2018 |
86,878 |
1,650,682
(4%)
|
0%
|
|
0
|
Common Stock |
Kenneth Sim
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2018 |
93,451 |
1,775,560
(5%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Co-Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2018 |
93,451 |
1,775,560
(5%)
|
0%
|
|
0
|
Common Stock |
Albert Young
|
Co-Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Dec 2018 |
47,971 |
911,446
(2%)
|
0%
|
|
0
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 17.31 per share. |
26 Nov 2018 |
30,000 |
559,438
(1%)
|
0%
|
17.3 |
519,300
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 17.91 per share. |
26 Nov 2018 |
20,000 |
589,438
(1%)
|
0%
|
17.9 |
358,200
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 17.07 per share. |
21 Nov 2018 |
20,000 |
609,438
(1%)
|
0%
|
17.1 |
341,400
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 16.21 per share. |
21 Nov 2018 |
30,000 |
629,438
(1%)
|
0%
|
16.2 |
486,300
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 18.97 per share. |
19 Nov 2018 |
20,000 |
679,438
(1%)
|
0%
|
19.0 |
379,400
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 17.58 per share. |
19 Nov 2018 |
20,000 |
659,438
(1%)
|
0%
|
17.6 |
351,600
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.56 per share. |
19 Nov 2018 |
77,868 |
834,470
(2%)
|
0%
|
18.6 |
1,445,215
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 16.51 per share. |
19 Nov 2018 |
75,000 |
690,741
(2%)
|
0%
|
16.5 |
1,238,100
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 17.55 per share. |
19 Nov 2018 |
68,729 |
765,741
(2%)
|
0%
|
17.6 |
1,206,435
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 16.01 per share. |
07 Sep 2018 |
7,886 |
912,338
(2%)
|
0%
|
16.0 |
126,255
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 15.02 per share. |
07 Sep 2018 |
25,688 |
920,224
(2%)
|
0%
|
15.0 |
385,834
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 16.03 per share. |
29 Aug 2018 |
15,000 |
707,338
(2%)
|
0%
|
16.0 |
240,450
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.76 per share. |
29 Aug 2018 |
7,900 |
699,438
(2%)
|
0%
|
15.8 |
124,504
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 17.35 per share. |
27 Aug 2018 |
15,000 |
737,338
(2%)
|
0%
|
17.4 |
260,250
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 16.65 per share. |
27 Aug 2018 |
15,000 |
722,338
(2%)
|
0%
|
16.7 |
249,750
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 17.35 per share. |
27 Aug 2018 |
25,000 |
945,912
(2%)
|
0%
|
17.4 |
433,750
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Aug 2018 |
18,574 |
4,826
|
-
|
|
-
|
Stock Option (right to buy) |
Adrian Vazquez
|
Co-Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Aug 2018 |
10,000 |
23,400
|
-
|
|
-
|
Stock Option (right to buy) |
Adrian Vazquez
|
Co-Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Aug 2018 |
30,000 |
33,400
|
-
|
|
-
|
Stock Option (right to buy) |
Adrian Vazquez
|
Co-Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. |
24 Aug 2018 |
18,574 |
970,912
(2%)
|
0%
|
6.4 |
118,316
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. |
24 Aug 2018 |
10,000 |
952,338
(2%)
|
0%
|
10 |
100,000
|
Common Stock |
Adrian Vazquez
|
Co-Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. |
24 Aug 2018 |
30,000 |
942,338
(2%)
|
0%
|
1.5 |
45,000
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 16.47 per share. |
23 Aug 2018 |
15,000 |
752,338
(2%)
|
0%
|
16.5 |
247,050
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.97 per share. |
23 Aug 2018 |
18,000 |
767,338
(2%)
|
0%
|
16.0 |
287,460
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 16.73 per share. |
21 Aug 2018 |
15,000 |
800,338
(2%)
|
0%
|
16.7 |
250,950
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 16.32 per share. |
21 Aug 2018 |
15,000 |
785,338
(2%)
|
0%
|
16.3 |
244,800
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 18.51 per share. |
17 Aug 2018 |
10,000 |
827,338
(2%)
|
0%
|
18.5 |
185,100
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 17.75 per share. |
17 Aug 2018 |
12,000 |
815,338
(2%)
|
0%
|
17.8 |
213,000
|
Common Stock |
Gary M. Augusta
|
None |
Sale of securities on an exchange or to another person at price $ 18.71 per share. |
17 Aug 2018 |
12,948 |
152,997
(0%)
|
0%
|
18.7 |
242,218
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 16.35 per share. |
14 Jun 2018 |
20,000 |
837,338
(2%)
|
0%
|
16.4 |
327,000
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.44 per share. |
12 Jun 2018 |
13,000 |
872,338
(2%)
|
0%
|
15.4 |
200,720
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.77 per share. |
12 Jun 2018 |
15,000 |
857,338
(2%)
|
0%
|
15.8 |
236,550
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.44 per share. |
08 Jun 2018 |
12,000 |
885,338
(2%)
|
0%
|
15.4 |
185,280
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.73 per share. |
08 Jun 2018 |
8,000 |
897,338
(2%)
|
0%
|
14.7 |
117,840
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.20 per share. |
06 Jun 2018 |
14,535 |
905,338
(2%)
|
0%
|
14.2 |
206,397
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.70 per share. |
06 Jun 2018 |
13,876 |
919,873
(2%)
|
0%
|
14.7 |
203,977
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.85 per share. |
04 Jun 2018 |
13,876 |
933,749
(2%)
|
0%
|
14.9 |
206,059
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.78 per share. |
04 Jun 2018 |
13,876 |
947,625
(2%)
|
0%
|
14.8 |
205,087
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.37 per share. |
31 May 2018 |
11,876 |
961,501
(2%)
|
0%
|
14.4 |
170,658
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 13.63 per share. |
31 May 2018 |
9,476 |
973,377
(2%)
|
0%
|
13.6 |
129,158
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 13.28 per share. |
29 May 2018 |
5,876 |
982,853
(2%)
|
0%
|
13.3 |
78,033
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 13.52 per share. |
29 May 2018 |
5,876 |
988,729
(2%)
|
0%
|
13.5 |
79,444
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 13.70 per share. |
24 May 2018 |
5,876 |
994,605
(2%)
|
0%
|
13.7 |
80,501
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.19 per share. |
24 May 2018 |
5,876 |
1,000,481
(3%)
|
0%
|
14.2 |
83,380
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 14.69 per share. |
22 May 2018 |
5,876 |
1,006,357
(3%)
|
0%
|
14.7 |
86,318
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.39 per share. |
22 May 2018 |
5,876 |
1,012,233
(3%)
|
0%
|
15.4 |
90,432
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.90 per share. |
18 May 2018 |
5,876 |
1,023,985
(3%)
|
0%
|
15.9 |
93,428
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 15.66 per share. |
18 May 2018 |
5,876 |
1,018,109
(3%)
|
0%
|
15.7 |
92,018
|
Common Stock |
Hing Ang
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Mar 2018 |
37,593 |
37,593
(0%)
|
0%
|
|
0
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2018 |
22,476 |
71,024
|
-
|
|
-
|
Stock Option |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.90 per share. |
15 Jan 2018 |
4,953 |
1,029,861
(3%)
|
0%
|
28.9 |
143,142
|
Common Stock |
Warren Hosseinion
|
Director, Co-Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. |
15 Jan 2018 |
22,476 |
1,034,814
(3%)
|
0%
|
6.4 |
143,172
|
Common Stock |
Mihir Shah
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share. |
15 Jan 2018 |
23,610 |
23,610
(0%)
|
0%
|
4.5 |
106,245
|
Common Stock |
Mihir Shah
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2018 |
23,610 |
26,390
|
-
|
|
-
|
Stock Option |
Mihir Shah
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.90 per share. |
15 Jan 2018 |
3,678 |
19,932
(0%)
|
0%
|
28.9 |
106,294
|
Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
08 Dec 2017 |
52,263 |
52,262
|
-
|
|
-
|
Warrants to purchase Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
08 Dec 2017 |
1,682,109 |
1,682,109
(5%)
|
5%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
08 Dec 2017 |
1,664,054 |
1,664,054
(5%)
|
5%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
08 Dec 2017 |
1,563,763 |
1,563,763
(4%)
|
4%
|
|
0
|
Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
08 Dec 2017 |
68,317 |
68,317
|
-
|
|
-
|
Warrants to purchase Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
08 Dec 2017 |
34,159 |
34,158
|
-
|
|
-
|
Warrants to purchase Common Stock |
Thomas S. Lam
|
Director, Co-Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
08 Dec 2017 |
55,337 |
55,337
|
-
|
|
-
|
Warrants to purchase Common Stock |
Warren Hosseinion
|
Director, Chief Executive Officer, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Apr 2017 |
23,363 |
23,363
|
-
|
|
-
|
Stock Option (right to buy) |
Warren Hosseinion
|
Director, Chief Executive Officer, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Apr 2017 |
6,637 |
6,637
|
-
|
|
-
|
Stock Option (right to buy) |
Adrian Vazquez
|
Chief Medical Officer, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Apr 2017 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (right to buy) |
Gary M. Augusta
|
Director, Chairman of the Board |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Apr 2017 |
15,000 |
15,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mihir Shah
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Apr 2017 |
10,000 |
10,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mihir Shah
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Nov 2016 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (right to buy) |
Warren Hosseinion
|
Director, Chief Executive Officer, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
93,500 |
93,500
|
-
|
|
-
|
Stock Option (right to buy) |
Suresh T. Nihalani
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Suresh T. Nihalani
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Adrian Vazquez
|
Chief Medical Officer, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
23,400 |
23,400
|
-
|
|
-
|
Stock Option (right to buy) |
Gary M. Augusta
|
Director, Executive Chairman |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
93,500 |
93,500
|
-
|
|
-
|
Stock Option (right to buy) |
David Schmidt
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
David Schmidt
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mark Fawcett
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
20,000 |
20,000
|
-
|
|
-
|
Common Stock |
Mark Fawcett
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
15,000 |
15,000
|
-
|
|
-
|
Stock Option (right to buy) |
Edward Schreck
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Edward Schreck
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Sep 2016 |
20,000 |
20,000
|
-
|
|
-
|
Stock Option (right to buy) |
Thomas S. Lam
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
30 Mar 2016 |
555,555 |
555,555
|
-
|
|
-
|
Series B Preferred Stock |
Thomas S. Lam
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
30 Mar 2016 |
555,555 |
1,666,666
|
-
|
|
-
|
Warrants to purchase Common Stock |
Mitch Creem
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2015 |
500 |
500
|
-
|
|
-
|
Option |
Mitch Creem
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2015 |
500 |
500
|
-
|
|
-
|
Option |
Mitch Creem
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Jan 2015 |
500 |
500
|
-
|
|
-
|
Option |
Gary M. Augusta
|
Director, Executive Chairman |
Other type of transaction at price $ 0.00 per share. |
30 Apr 2013 |
100,000 |
1,659,457
|
-
|
|
-
|
Common Stock |
Noel DeWinter
|
Chief Financial Officer |
|
31 Jan 2010 |
250,000 |
250,000
|
-
|
|
-
|
Common Stock, par value $.001 per share |
Suresh T. Nihalani
|
None |
|
31 Jan 2010 |
400,000 |
400,000
|
-
|
|
-
|
Common Stock, par value $.001 per share |
Bradley S. Shepherd
|
Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
20 May 2005 |
1,800,000 |
10,200,000
|
-
|
|
-
|
Common Stock |